Related European programmes 18.02.2014 | Budapest - Hungary Dr Cristina Pascual | National Documentation Centre - EKT 18.02.2014 Related European programmes BUDAPEST Horizon 2020: Public-Public (P2Ps) & Public-Private (PPPs) Partnerships • Innovative Medicines Initiative (PPP): IMI & IMI-2 • European & Developing Countries Clinical Trials Partnership (P2P): EDCTP & EDCTP2 • Ambient Assisted Living Joint Programme (P2P): AAL JP & AAL JP-2 • ERA-NETs (P2P) in Health sector • Joint Programming Initiatives (P2P) in Health sector European Innovation Partnership in Active & Healthy Ageing EIP AHA COST Programme Health & Health for Growth Programme of DG SANCO 2 © Fit for Health 2.0, 2014 18.02.2014 Related European programmes BUDAPEST Horizon 2020: P2Ps, PPPs & EIPs Public-Private Partnerships (PPPs): Funding Instruments which bring together private (industry) & public actors (EC & Member States (MS)) for the development of selected strategic technologies essential to EU competitiveness Public-Public Partnerships (P2Ps): Funding Instruments for the implementation of a less fragmented & more efficient European Research Area through the coordination & harmonisation of National R&I strategies in European priorities areas European Innovation Partnerships: Not funding, challenge-driven instruments, bringing together all public & private actors at EU, national and regional level across the whole research & innovation chain (coordination of R&D efforts & of investments in demonstration & pilots actions; anticipation & fast track for regulation & standards needed; easy access to market through coordination public procurement) 3 © Fit for Health 2.0, 2014 18.02.2014 Related European programmes BUDAPEST Innovative Medicines Initiative – IMI (PPP) Joint Technology Initiative (JTI) of the 7th Framework Programme (FP7) Joint Undertaking (PPP) between EU & EFPIA (European Federation of Pharmaceutical Industries & Associations) Aims at making the drug discovery & development process in Europe more efficient, to bring better medicines faster to patients IMI calls addressed to: universities, research organisations, SMEs, industry (EFPIA members & other industrial partners), patients’ organisations, hospitals, regulatory agencies 4 © Fit for Health 2.0, 2014 18.02.2014 Related European programmes BUDAPEST Innovative Medicines Initiative - IMI IMI supports collaborative research projects following open & competitive calls with a peer review process by independent experts Project funding via combined contributions from • Public funds goes exclusively to academia, public organizations, SMEs, patients associations, … • Private – as ‘in kind’ pharmaceutical companies contributions from the participating Average project size 20 million € Average partnership 10-15 pharmaceutical companies & 10-15 academic, SME, regulatory, patient organizations http://www.imi.europa.eu www.imi-partnering.eu (Partner search tool) 5 © Fit for Health 2.0, 2014 18.02.2014 Related European programmes BUDAPEST IMI – Call 11 Launched on the 11/12/2013 Topics on: • Osteoarthritis, Alzheimer’s Disease, Blood-based biomarker assays for personalised tumour therapy, zoonoses, research tools to translate genomic discoveries into drug discovery projects, EcoRisk Prediction, healthcare-associated infections due to Gram-negative pathogens, novel inhaled antibiotic regimens in patients with cystic fibrosis (CF) & non-CF bronchiectasis (BE) Budget ~171 Mio. € IMI JU (EC) + ~201 Mio. € EFPIA Deadline for “Expression of Interest” 08/04/2014 http://www.imi.europa.eu/content/stage-1-11 6 © Fit for Health 2.0, 2014 18.02.2014 Related European programmes BUDAPEST Innovative Medicines Initiative 2 – IMI 2 IMI-2 will help to implement Societal Challenge 1 (SC1) Aims to develop the next generation of cost-efficient vaccines, medicines & treatments that Europe desperately needs including new fields such as biomedical imaging Budget: €3.45 billion (2014 – 2024) Start date: January 2014 http://www.imi.europa.eu/content/imi-2 7 © Fit for Health 2.0, 2014 18.02.2014 Related European programmes BUDAPEST European & Developing Countries Clinical Trials Partnership - EDCTP (P2P) Cooperative measure of the EC, MS & Sub-Saharan African states Aim: accelerate the development of new or improved drugs, vaccines & microbicides against HIV/AIDS, malaria & tuberculosis, with a focus on phase II & III clinical trials in sub-Saharan Africa Topics on clinical trials, networking & capacity building activities Address to: universities, research organisations, NGOs, SMEs, industry, hospitals, patients’ organisations Financial contribution from the EC, MS & Africa EDCTP will continue as EDCTP2 in 2014, as part of Horizon 2020 http://www.edctp.org/ http://www.edctp.org/Current_Calls.405.0.html http://www.edctp.org/Towards_EDCTP2.799.0.html 8 © Fit for Health 2.0, 2014 18.02.2014 Related European programmes BUDAPEST Ambient Assisted Living Joint Programme – AAL JP (P2P) AAL JP: close-to-market, demand-driven research for ageing well with ICT Joint programme between EC & 22 countries (19 MS & 3 AC= AAL Partner States) Aim: Enhance the quality of life of older people & strengthen the industrial base in EU through the use of ICT Top-down topics (pre-defined) Calls addressed to: universities, research organisations, industry, SMEs and end-users (at least 3 partners from 3 different AAL Partner States, including 1 SME & 1 end-user organisation) http://www.aal-europe.eu/ 9 © Fit for Health 2.0, 2014 18.02.2014 Related European programmes BUDAPEST Ambient Assisted Living Joint Programme – AAL JP-2 (P2P) Aim: support industry, in particular SME to bring digital innovative products & services for ageing well to the EU market Added value: Alignment with the European Innovation Partnership on Active & Healthy Ageing (EIP AHA) to reinforce the European market for AAL products & services http://www.aal-europe.eu/ 10 © Fit for Health 2.0, 2014 18.02.2014 Related European programmes BUDAPEST European Research Area Networks ERA-NETs in Health (P2P) ES S I F CP CP CP* CP ERA-NET DE Prog Prog Prog Prog Prog F S I ES DE … CP Single national Calls for Projects Common transnational Call for Projects • EC Financial topping up joint call budget of max 33% • Small % for call management • Most of EU funding for research ERA-NET Co-fund instrument (Horizon 2020): replace ERA-NET & ERANET Plus actions 11 • Financial support for up to 5 years for coordination & joint transnational call for proposal(s) launched by national & regional funding programmes with a common thematic focus and EU added value • Call for establishment of ERA-NETS are launched top-down © Fit for Health 2.0, 2014 18.02.2014 Related European programmes BUDAPEST ERA-NETs in Health (P2P) ERA-NETs are addressed to actors implementing public research programmes (programme owners or programme managers) from MS & AC to coordinate their activities at EU level (at least 3 participants from 3 different MS/AC). Calls for proposals launched by ERA-NETs are addressed to: universities, research organisations, enterprises (depending on ERANETs) • • At least 2 participants from at least 2 different MS or AC Applicants should contact the national funding organisation implementing the ERA-NET NEURON 2 – Diseases related Neurosciences (open call 10/01/2014 – 10/03/2014; Topic: "European Research Projects on Neuroinflammation“) http://www.neuron-eranet.org ERare 2 – Rare Diseases (no current call); http://www.e-rare.eu Euronanomed- Nanomedicine (open call: 5th Call for Proposals of the EuroNanomed initiative http://www.euronanomed.net/ 12 26/11/2013 – 04/03/2014) © Fit for Health 2.0, 2014 18.02.2014 Related European programmes BUDAPEST ERA-NETs in Health (P2P) Infect-ERA Humane – Infections Diseases (Open call: 2nd Call with deadline 03/04/2014; 2 topics on Commensal flora in homeostasis & microbe’s pathogenicity, their use to prevent or treat infections; New techniques to investigate the initial steps of the infection process) http://www.infect-era.eu/ EuroTrans-Bio – Biotech SMEs; http://www.eurotransbio.eu/ TransCAN –Translational Cancer Research (3rd Call preproposal submission deadline 03/02/2014; full proposal submission 10/06/2014; Topic: "Translational research on tertiary prevention in cancer patients”) http://www.transcanfp7.eu Information on open calls at NETWATCH: http://netwatch.jrc.ec.europa.eu/web/ni/network-information/joint-calls Does your country/region participate in? 13 © Fit for Health 2.0, 2014 18.02.2014 Related European programmes BUDAPEST Joint Programming Initiatives - JPIs (P2Ps) Coordination of national research efforts in order to tackle common European challenges in a more effective & efficient way Member States collaborate on a voluntary basis & pool their resources to address global social problems - great challenges: • 1. Identification of a common vision • 2. Definition of Research Strategic Agenda (RSA) • 3. Implementation of RSA in a Joint Programming Initiative (JPI) 14 Once established JPIs launch calls that are addressed to: universities, research organisations, NGOs & SMEs (depending on JPI) © Fit for Health 2.0, 2014 18.02.2014 Related European programmes BUDAPEST Joint Programming Initiatives in Health JPI “Neurodegenerative Diseases Research” • • JPI Demographic “More years, better lives” • http://www.jp-demographic.eu/ JPI “Antimicrobial Resistance” • Open call: 1st Joint Transnational call “InnovaResistance: Innovative • Open call: 2 Joint Transnational calls with deadlines 18 & 20/02/2014 http://www.neurodegenerationresearch.eu / approaches to address antibacterial resistance” with pre-proposal submission deadline of 14/03/2014) http://www.jpiamr.eu/ JPI “A healthy diet for a healthy life” • https://www.healthydietforhealthylife.eu Information on open calls at NETWATCH http://netwatch.jrc.ec.europa.eu/web/ni/network-information/joint-calls Does your country/region participate in? 15 © Fit for Health 2.0, 2014 18.02.2014 Related European programmes BUDAPEST European Innovation Partnership on Active & Healthy Ageing – EIP AHA EIP AHA is a cooperation of EU, regions, industry, research institutions and healthcare professionals: • • • . 16 Challenge-driven: health & an ageing population Focusing on societal benefits: to improve the quality of life of older people & the sustainability & efficiency of social & health care systems Targeting a rapid modernisation & increased competitiveness of the EU market for innovative products & services responding to the ageing challenge. EIPs are not funding instruments, but for coordination with broader R&I policies & programmes (i.e. topics in SC1 Work Programme) http://ec.europa.eu/active-healthy-ageing © Fit for Health 2.0, 2014 18.02.2014 Related European programmes BUDAPEST European Cooperation in Science & Technology - COST Programme Intergovernmental framework of national funded basic to precompetitive research coordinated on EU level Enhance research & innovation progress through creation of new international networks: • • Connect scientists with policy-makers, governmental & regulatory bodies, industry, spin-offs Bridging research communities: precursor of advanced multidisciplinary research No topics imposed: “Bottom-up” approach Address to: Universities, research institutes, Industry, SMEs Light-weight administration & flexible implementation: continuous open call for proposals with cut-off dates & two-stages submission (short & then full-proposal) 17 Does not fund research activities per se but coordination & networking © Fit for Health 2.0, 2014 18.02.2014 Related European programmes BUDAPEST COST Funded Action in the HEALTH Sector http://www.cost.esf.org Call oc-2014-1: Cut Off Date 1= 28 March 2014 http://w3.cost.eu/index.php?id=1528 18 © Fit for Health 2.0, 2014 18.02.2014 Related European programmes BUDAPEST Health Programme 2008-2013 & Health for Growth Programme 2014-2020 (DG SANCO) Health Programme 2008-2013 • • Main financial instrument to implement EU Health policy managed by EAHC (Executive Agency for Health and Consumer) Participants: 28 MS, + EFTA/EEA countries (Island, Lichtenstein, Norway) (Other countries institutions only as subcontracted or collaborating partners) • • • Aim: health inequalities, cross-border issues, illnesses caused by the most widespread diseases, such as cancer, and addressing mental health. Three priorities: health safety, promotion & information Calls addressed to wide range of organisations: research organisations, universities, public authorities, public health organisations, industry, SMEs, NGOs, patients’ organisations • 19 http://ec.europa.eu/health/programme/policy/index_en.htm Health for Growth Programme 2014-2020: • Budget of 449 Mio € (to be adopted 2014) • http://ec.europa.eu/health/programme/policy/2014-2020/state_of_play_en.htm © Fit for Health 2.0, 2014 18.02.2014 Related European programmes BUDAPEST Joint Action funded by HEALTH - DG SANCO Improving Quality in HIV Prevention (QHP) (Joint Action No 20122102 ) Programme Acronym: HEALTH – DG SANCO Objective: Quality Action is the EU-wide ‘Joint Action on Improving Quality in HIV Prevention’. The project brings together 25 associated and 17 collaborating partners from 25 Member States. Quality Action contributes to the implementation of the EC Communication: ‘Combating HIV/AIDS in the European Union and neighbouring countries (2009 - 2013)’. Quality Action aims to increase the effectiveness of HIV prevention in Europe by using practical Quality Assurance (QA) and Quality Improvement (QI) tools. Quality Action develops and adapts QA/ QI tools especially for use in HIV prevention. The project will train at least 60 trainers and facilitators to support at least 80 HIV prevention programs and projects across the EU that will be applying the QA/QI tools. 20 © Fit for Health 2.0, 2014 18.02.2014 Related European programmes BUDAPEST Your organisation logo Thank you! Dr Cristina Pascual | EKT [email protected] | www.ekt.gr The copyright © is owned by the author of this document. Please do not duplicate. Disclaimer: The "Fit for Health2.0" project partners do not assume any legal liability or responsibilities for the information provided in this document.
© Copyright 2018 ExploreDoc